Cite
HARVARD Citation
Calza, L. et al. (2022). Changes in Serum Inflammatory Markers in Antiretroviral Therapy–Naive HIV-Infected Patients Starting Dolutegravir/Lamivudine or Dolutegravir/Lamivudine/Abacavir. Journal of acquired immune deficiency syndromes. p. . [Online].